Національний Медичний Університет Ім. О. О. Богомольця
Национальный Медицинский Университет Им. О.О. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Ім. О. О. Богомольця, Национальный Медицинский Университет Им. О.О. БогомольцаfiledCriticalНаціональний Медичний Університет Ім. О. О. Богомольця
Priority to UA99042488ApriorityCriticalpatent/UA33946A/en
Publication of UA33946ApublicationCriticalpatent/UA33946A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The method comprises the use of the drugs. Flamicar is administered at a dose of 500 mg thrice a day for three weeks in the setting of the basic therapy, the sparing regimen, and the diet.
UA99042488A1999-04-301999-04-30Method for treating alcohol disease of liver
UA33946A
(en)
Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film
THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA